Results 101 to 110 of about 982 (163)

Systemic metabolic reprogramming and microbial dysbiosis in Fabry disease: Multi-omics mechanisms and implications for drug development. [PDF]

open access: yesFront Pharmacol
Gómez-Cebrián N   +5 more
europepmc   +1 more source

Fabry disease in the haemodialysis population: outcome of a UK screening study (SoFAH). [PDF]

open access: yesBMC Nephrol
Ng KP   +13 more
europepmc   +1 more source

Elevated circulating cell-free mitochondrial DNA in fabry disease: insights into inflammatory activation. [PDF]

open access: yesFront Immunol
Yuan Y   +10 more
europepmc   +1 more source

Impact of enzyme replacement therapy and migalastat on disease progression in females with fabry disease. [PDF]

open access: yesOrphanet J Rare Dis
Lenders M   +7 more
europepmc   +1 more source

Cellular Lyso-Gb3 Is a Biomarker for Mucolipidosis II. [PDF]

open access: yesInt J Mol Sci
Terawaki S   +4 more
europepmc   +1 more source

Proton Density of the Dorsal Root Ganglia in Classical Fabry Disease: MRI Correlates of Small Fibre Neuropathy. [PDF]

open access: yesBiomedicines
Weiner S   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy